Anti-CA19-9 mAb
Cancer antigen 19-9 refers to a tumor marker associated with pancreatic, gallbladder, colon, and stomach cancers and is also known as an associated gastrointestinal antigen. Ca19-9 cancer marker has high sensitivity and specificity for pancreatic cancer. Detection of CA19-9 is helpful for differential diagnosis, disease monitoring, and diagnosis of pancreatic cancer metastasis. If you want to know more antigen markers, you can found in our website.
Details
The comparison study between Sekbio’s Ab(CA19-9) and Roche kit
Coated Ab: HA111-1M
conjugated Ab: HA111-1H
The comparison study between Sekio's Ab(CA19-9, 1G12M) and Cang's
Coated Ab: HA111-4M
Conjugated Ab: HA111-4M
Related Immunoassays
- Cardiac Markers
-
Tumor Marker
-
PGII
-
G17
- CA50
-
CA125
- CA242
-
CA15-3
- CA19-9
- CA72-4
-
Pepsinogens I (PGI)
-
Human Epididymis 4 (HE4)
- Prostate-Specific Antigen (PSA)
- Squamous Cell Carcinoma (SCC)
- Neuron-Specific Enolase (NSE)
- Cytokeratin 19 Fragment (CYFRA21-1)
- Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
- Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
- Alpha-fetoprotein(AFP)
-
CEA
-
Human Chitinase 3-like 1
-
PGII
- Inflammatory Marker
- Infectious Disease
- Hormones
- Thyroid Function
- Glucose Metabolism
- Bone Marker
- Others
-
Heterophilic Blocking Reagent
- Animal Diagnostics
